Command Palette

Search for a command to run...

INDRAMEDCO
566.95(-0.05%)
1W: +27.53%

Indraprastha Medical Corporation Peer Comparison

Snapshot Summary

Indraprastha Medical Corporation Ltd. is significantly lagging behind its peers in key financial metrics, showing no growth in revenue or earnings, and suffering from a lack of profitability and efficiency. This positions it as a potential underperformer in the Hospital & Healthcare Services sector, especially compared to its competitors who demonstrate stronger growth, profitability, and valuation metrics.

  • Indraprastha shows 0% revenue growth YoY and over 3 years, while peers show robust growth.
  • The company has no return on equity, contrasting sharply with peers like Narayana Hrudayalaya with 24.27%.
  • The PE ratio of 25.50 suggests it is overvalued given its lack of earnings growth.
  • Max Healthcare has the highest profitability metrics among peers, while Indraprastha is unprofitable.
  • Max Healthcare Institute Ltd.: Strong revenue growth (18.49% YoY), high ROE (13.47%), and significant market cap.
  • Narayana Hrudayalaya Ltd.: High ROE (24.27%) and solid profitability metrics.
  • Apollo Hospitals Enterprise Ltd.: Strong EPS growth and high ROE (20.51%).
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
INDRAMEDCO₹447.75₹4,104.66Cr25.50--
MAXHEALTH₹1,179.65₹1,14,679.30Cr163.5816.26%0.14
APOLLOHOSP₹7,676.95₹1,10,383.03Cr85.1521.19%0.67
FORTIS₹924.85₹69,822.29Cr1094.6312.01%0.11
MEDANTA₹1,395.25₹37,474.60Cr81.2620.50%0.10
NH₹1,784.05₹36,459.02Cr84.5621.62%0.61
ASTERDM₹605.10₹30,225.53Cr5.0511.46%0.19

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.